Moustakli Efthalia, Zagorianakou Nektaria, Makrydimas Stylianos, Oikonomou Emmanouil D, Miltiadous Andreas, Makrydimas George
Laboratory of Medical Genetics, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece.
Human Computer Interaction Laboratory, Department of Informatics and Telecommunications, University of Ioannina, Kostakioi, 47150 Arta, Greece.
Genes (Basel). 2025 Jul 30;16(8):918. doi: 10.3390/genes16080918.
: Endometriosis is a chronic, estrogen-driven gynecological disorder affecting approximately 10% of reproductive-aged women worldwide, with significant physical, psychosocial, and socioeconomic impacts. Recent research suggests a possible involvement of the gut microbiome in endometriosis disease mechanisms through immune manipulation, estrogen metabolism, and inflammatory networks. This narrative review aims to summarize current evidence on gut microbiota changes in endometriosis patients, explore the mechanisms by which gut dysbiosis contributes to disease progression, and examine epidemiological links between gastrointestinal health and endometriosis risk. : A narrative review was conducted to synthesize available literature on the compositional changes in gut microbiota associated with endometriosis. The review also evaluated studies investigating potential mechanisms and epidemiological patterns connecting gut health with endometriosis development and severity. : Alterations in gut microbiota composition were observed in endometriosis patients, suggesting roles in immune dysregulation, estrogen metabolism, and inflammation. Potential gut-oriented interventions, including dietary changes, probiotics, and lifestyle modifications, emerged as promising management options. However, methodological variability and research gaps remain barriers to clinical translation. : Integrating gut microbiome research into endometriosis management holds potential for improving early diagnosis, patient outcomes, and healthcare system sustainability. The study emphasizes the need for further research to address existing challenges and to develop public health strategies that incorporate microbiome-based interventions in population-level endometriosis care.
子宫内膜异位症是一种慢性的、由雌激素驱动的妇科疾病,影响着全球约10%的育龄妇女,对身体、心理社会和社会经济都有重大影响。最近的研究表明,肠道微生物群可能通过免疫调节、雌激素代谢和炎症网络参与子宫内膜异位症的发病机制。本叙述性综述旨在总结目前关于子宫内膜异位症患者肠道微生物群变化的证据,探讨肠道生态失调促进疾病进展的机制,并研究胃肠道健康与子宫内膜异位症风险之间的流行病学联系。:进行了一项叙述性综述,以综合有关与子宫内膜异位症相关的肠道微生物群组成变化的现有文献。该综述还评估了调查将肠道健康与子宫内膜异位症发展及严重程度联系起来的潜在机制和流行病学模式的研究。:在子宫内膜异位症患者中观察到肠道微生物群组成的改变,表明其在免疫失调、雌激素代谢和炎症中发挥作用。包括饮食改变、益生菌和生活方式调整在内的潜在肠道导向干预措施,成为有前景的管理选择。然而,方法学的变异性和研究空白仍然是临床转化的障碍。:将肠道微生物群研究纳入子宫内膜异位症管理中,对于改善早期诊断、患者预后和医疗系统可持续性具有潜力。该研究强调需要进一步研究以应对现有挑战,并制定在人群水平的子宫内膜异位症护理中纳入基于微生物群的干预措施的公共卫生策略。